Study: Less is better when it comes to aspirin after heart procedure

12/19/2012 | Modern Medicine

Higher doses of aspirin were associated with greater bleeding risks but not better ischemia outcomes in a study that followed 2,851 people after percutaneous coronary intervention for ST-segment elevation myocardial infarction. The study in the Journal of the American College of Cardiology: Cardiovascular Interventions examined three years of data from the HORIZONS-AMI trial.

View Full Article in:

Modern Medicine

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX